Caplin Point Laboratories (BOM:524742) YoY EBITDA Growth : 19.64% (As of Mar. 2025)

View and export this data going back to 2001. Start your Free Trial

What is Caplin Point Laboratories YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Caplin Point Laboratories's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 19.64%.

Caplin Point Laboratories's EBITDA per Share for the three months ended in Mar. 2025 was ₹25.43.

Caplin Point Laboratories YoY EBITDA Growth Historical Data

The historical data trend for Caplin Point Laboratories's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caplin Point Laboratories YoY EBITDA Growth Chart

Caplin Point Laboratories Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

YoY EBITDA Growth

Get a 7-Day Free Trial

16.72

22.98

14.50

24.78

20.10

Caplin Point Laboratories Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															19.16	22.89	17.21	21.04	19.64

Caplin Point Laboratories YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Caplin Point Laboratories's YoY EBITDA Growth for the fiscal year that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (A: Mar. 2025 )
=	(EBITDA per Share (A: Mar. 2025 )	-	EBITDA per Share (A: Mar. 2024 ))	/	\| EBITDA per Share (A: Mar. 2024 ) \|
=	(97.37	-	81.074)	/	\| 81.074 \|
=	20.10 %

Caplin Point Laboratories's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(25.433	-	21.258)	/	\| 21.258 \|
=	19.64 %

Caplin Point Laboratories YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Caplin Point Laboratories's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Caplin Point Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (BOM:524742) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

CAPLIPOINT:India

Address

Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096

Website

https://www.caplinpoint.net

Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, injections (liquid and lyophilized, prefilled syringes), ophthalmic solutions, liquid orals, soft gel capsules, ointments, creams, gels, powders for injections, suppositories, ovules, pre-mix bag formulations, inhalers, sprays, and IV infusions. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops.

Caplin Point Laboratories Headlines

No Headlines